MedPath

Dialert, effects of a lifestyle intervention in Dutch and Turkish 1st degree relatives of persons with type 2 diabetes, a randomised controlled trial.

Conditions
Diabetes Mellitus type 2, life style, prevention, intervention, overweight
Registration Number
NL-OMON26716
Lead Sponsor
EMGO Institute, VU University Medical Center
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
268
Inclusion Criteria

Eligible are first-degree relatives of type 2 diabetes patients (father, mother, brother or sister, son or daughter), between 25 and 65 years of age, and overweight (Body Mass Index of ≥ 25 or waist circumference > 88 cm for females and > 102 cm for males). In the Turkish group, both first and second generation Turkish immigrants are eligible.

Exclusion Criteria

Exclusion criteria are:

1. Diagnosed with type 1 or 2 diabetes;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main endpoint is to achieve significant reduce of body weight at 3 months following the intervention.
Secondary Outcome Measures
NameTimeMethod
Is there a significant difference in metabolic outcomes (weight, BMI, weight circumference, lipids, blood pressure, insulin resistance and HbA1c) psychological and behavioural outcomes (perceived risk and seriousness of diabetes, self-efficacy beliefs (diet, exercise, smoking), outcome expectancies, distress, motivation to change and self-reported health behaviours (diet, exercise, smoking, alcohol)) and psychological distress (anxiety an depression) from baseline to 3 months between intervention and controls and at 6 and 9 months following the intervention between and within both ethnic groups?<br /><br>Do baseline patient characteristics predict weight loss at 6 and 9 months follow-up, within and across both ethnic groups.
© Copyright 2025. All Rights Reserved by MedPath